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Editorial 
The Past and Future of Organ Transplantation 
I t  has now been thirty years since the burger and some of the other European 
first attempt was made a t  renal homo- authorities. 
transplantation in man. The early efforts In spite of the occasional encouraging 
to apply this form of therapy to the treat- experience, the prospect oi achieving sig- 
ment of terminal renal disease were doomed nificant clinical benefit from renal homo- 
to failure since they preceded an apprecia- transplantation in more than the isolated 
tion oi the problems to be encountered. case seemed remote indeed until the 
Knolvledqe oi homo,qait rejection was discox-ery by Schrvartz and Dameshek 
scanty. and the therapy necessary to pre- of the immunosuppressive properties of 
vent this process was not understood at all. 6-mercaptopurine in 1959 and the subse- 
Since that time, a rational explanation oi quent testing of this drug and its analogue, 
rejection has been provided by the studies Azathioprine, by Calne and Zukoski. I t  
of bIedawar and those of other investi- immediately became apparent that preven- 
gators. The evidence is overwhelming tion of homograft rejection could be 
that rejection is due to immunologic accomplished with greater regularity and 
repudiation of the alien tissue by the host. with less risk to the recipient than had 
The intensity of this reaction is related to been possible with total-body irradiation: 
the degree ol' genetic dissimilarity between long-term homograft viability was achieved 
the donor and the recipient. Its preven- in animals without the necessity oi con- 
tion depends to a greater or less extent comitant host leukopenia or agranulocyto- 
upon crippling the host's capacity for sis. During the ensuing several years, 
immunologic response to unfamiliar anti- clinical efforts a t  homotransplantation of 
gens. the kidney have proceeded with increasing 
The initial attempts at  potentiating regularity. By Sept. 13, 1964, almost 500 
homo,grait function by alteration of the such potentially therapeutic operations 
host were made with total-body irradiation. were known, by virtue of their entry into 
Such therapy proved to be of value for the the Sational Academy of Science Registry, 
prevention of rejection, but the requisite to have been performed throughout the 
dosage was so high that most of the re- world. 
cipient patients died from bone-marrow , The experience with clinical renal homo- 
depression and sepsis. Despite the ex- transplantation resulted in a number of 
orbitant risk imposed, 3 patients are still significant observations which had not been 
living irom this pioneer era, the longest appreciated from animal studies. I t  had 
follow-up being on a young man treated long been assumed that rejection was one 
almost six years ago by Murray and of nature's most powerful and persevering 
Slerrill ~vith a homograft from his fraternal reactions, which was inexorable when 
twin. Today, American centers do not once begun. I t  was soon learned that 
generally use total-body irradiation, al- rejection was a reversible process and, 
though it remains an important element more recently, evidence has accrued that it 
in the overall therapy employed by Ham- occasionally runs a spontaneously re- 
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Fig. 1. Results aitcr tbvbcen months*-in ti4 consecutive patients /rnC7d- 
treated a t  the L7tiiversity of Colorado Medical Center with renal homografts-,.-----' 
obtained from living volunteer donnrs. Identical twin cases are not i G3. 
7-:. ? t - L f h  occurred after one gear. Xote that 2two-thirds 
iji the patients who received kidneys irorn blood relatives are alive from thirrcefl JO 3-.t...--....----.- -- 
to ' months after transplantation. Onlv a third f those whose 
don=rciated lived as long as a year Lnd r r j  d w  ~ f i e * / J  dt(.d t* 
~*rry 4 p.- 4 d [,?r i&Gv& y 'w. 
mittent course. Al~though the cl~nical of little value for potentiation of homograft 
manifestations of rejection could be survival, but in- combination with kza- 
avoided in only a minority of cases, the thioprine, they play a crucial role in the 
adverse effects could be mitigated and mitication and reversal of an established 
- 
reversed in most instances. rejection. Secondary adjuvants which 
In the majority of centers the most im- have been useiul are actinomycin C and 
portant immunosuppressive agent used 
is .lzathioprine. This drug, which in- 
hibits nucleic acid synthesis, is started 
before or a t  the time of transplantation 
and continued indefinitely thereafter : it 
is a potentially dangerous agent since 
bone-marrow depression results from over- 
dosage, and even in small quantities it 
local homograft irradiation. 
The effectiveness of local homograf t 
irradiation for the prevention and treat- 
ment of rejection was established by the 
work of Hume and Goodwin and their 
associates. The explanation of the thera- 
peutic benefit is not known. During a 
rejection crisis, the kidney is infiltrated 
may be hepatotoxic. ~rednisone is also with cells and enlarges; the transplant 
essential. When used alone, steroids arc wound becomes tender. After the first 
v , , ~ .  85 EI)ITORI.\I~ 37 1 
dose oi 1.JO R ( a t  depth), t l~e  1oc:il signs grafts irom xenetically rclated donors were 
are oitCn tlramaticallv relieved, and soon used: two-thirds oi all those patients who 
,,iter there is frequently an impro\-ement received kidneys from 1)lood relatives are 
in the deteriorated renal function. Or- still living :r Fig. 1 1. With unrelated donors 
dinarily, the dose is repeated on three the results are poor sin( only one-third 
alternate days for a total of 4,50 R. Fur- lived for as long as one dr (Fig. 1). In 
ther investiqations are needed concerning our experience the l~est survival within 
the mechanism of this effect. In addition, the related group was ~vith parent-to- 
more precise knowledge is required of the oiTsprin transplants. 71) per cent oi t l ~ e  
potential irradiation injury to the Iiomo- recipients still bein: alive i Fig. 21. In 
graft which may be the penalty ior this the world experience, sibling-to-sibling 
short-term benefit. transiers have had the highest success 
Imperfect though the currently em- rate. 
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ployed therapeutic methods are, greatly These results indicate that many uremic 
improved earlv survival after renal homo- patients, perhaps even the majority, can be 
transplantation has been reported from materially benefited by renal homotrans- 
several centers, and it has already become plantation with relatively complete social 
possible to state with relative certainty and vocational rehabilitation over con- 
that homotransplantation will have an siderable periods of time. Severtheless, 
increasing role in the general medical workers in the field who have repeatedly 
armamentarium of the future. The re- warned that this treatment is experimental 
sults with recent clinical experience have are not yet willing to abandon this position. 
exceeded any hopes of even a few years The most important reason for a conserva- 
ago. Of the first 64 patients treated tive attitude is that the ultimate life ex- 
a t  the University of Colorado lledical pectancy of the present crop of chronic 
Center with kidneys from volunteer living survivors is still unknown. Barnes has 
donors, 37 homograft recipients lived for attempted to answer this question with 
at  least one year after operation (Fig. 1) a statistical analysis of the death rate of 
and 36 are still alive from thirteen to those patients already treated and has 
twenty-nine months (mean nineteen predicted that further losses from that 
months). IVithin this time limit, the group of patients still living will occur a t  
results approach acceptability if homo- an extremelv gradual rate. 
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\\liethcr this is true or not can he de- I)e required to studv tliese and many othcr 
termined only by actual observation. In important problems. 
the Incantime there is le~gitimate reason 'The potential applicability oi nti\ lnces 
lor avoiding overoptimism. S o t  all pa- in homotransplantation is, of course, not 
ticnts who have reached a chronic stage of limited to the field of renal disease. In 
~,ouvalescence are well. In many, there is future years, i t  seems inevitable that other 
c\-itiencc oi continued host-aqainst-grait kinds of mono-organ failure will be treated 
Irnrnur~oioqic activity rnarliiested in some with functional liomografts. -llready, at- 
C L I S ~ S  i)]i. acute episodes of late rejection. in tempts have been made in man to trans- 
otllers by histo10,qic evidence oi active plant the heart, lung, and liver. X1- 
rejection despite perfectly functioning though protracted survival has yet to be 
llomoqraits, and in still others bv a slow obtained in man with any of these organs, 
and insidious deterioration of function. I t  the difficulties encountered have not seemed 
is possible that most of the apparently well inherently insolvable. Survival of a year 
patients are living by virtue of renal or longer has been accomplished in dogs 
11omo:rafts which are losing a small frac- with all three types of homograits, and 
tion oi functioning parenchyma each day. with livers the regularity with which 
For the moment, therefore, it would seem long-tern1 success can be achiel-ed equals 
most reasonable to regard renal homo- that reported with canine kidneys. 'These 
transplantation as an ehective, but in- findings suggest that strong organ-specific 
completely characterized, form of palliative antigens will not make the control oi 
therapy. Ultimately i t  mav be proved rejection more difficult and that the 
to 11e a curative procedure, but that time immunosuppressive methods mill have an 
lias not yet arrived. interchangeable efficacy with different 
-1cceptance that human renal homo- homotransplanted tissues. This is not 
transplantation is still an exercise in to imply that success will be as readily 
clinical investigation may slow the wide- attainable as with kidneys. The prob- 
spread use of this procedure and hopefully lems of surgical technic are more for- 
confine its application to appropriately midable. Special physiologic problems 
 quipped institutions in ~vhich the clinical concerning denervation and blood supply 
program is only one component of an have been encountered. The necessity 
overall transplantation effort. Under for use of cadaveric organs limitsboth the 
these circumstances, potentially significant quantity and quality of supply. Finally, 
discoveries in the animal laboratories can the secondary illness and deterioration 
t,e tested on the wards with a minimum of homograft function during a potentially 
delay : conversely, observations on pa- reversible rejection of such organs may 
tients will influence the direction of basic carry a far more serious implication than 
research. with the kidney, since effective estra- 
'To illustrate the interdisciplinaq na- corporeal hearts, livers, and lungs have not 
cure oi the undertaking, one need only reached the stage of perfection which 
to mention the necessity of identifying would allow their emergency use for several 
iluman histocompatibilitv antigens for days or weeks during a postoperative 
improvement of future donor-recipient rejection episode. 
matching, or the desirability of establish- THOMAS E. STARZL, X D . ,  Ph.D. 
ing whether the thymus has the same role Professor of Surgery 
in recovery from immunologic depression THONAS L. ~ T A R C H I O R O ,  3I.D. 
in man as i t  apparently does in adult mice. L-lssistant Professor of Sl~rgery; +Unrkle 
The collaborative efforts of immunologists, Sclzolar, Ctzi.(*ersity o f  Colorado .School of 
surgeons, internists, and physiologists will Jfedicine, Denver, C'olo. 
